Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 9/20 | 0.48 |
| ▸ | ITGAV | P06756 | 9/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | ITGB5 | P18084 | 4/20 | 0.41 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.39 |
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.39 |
| ▸ | BTK | Q06187 | 1/20 | 0.38 |
| ▸ | PROKR1 | Q8TCW9 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8474796 | 0.91 | ITGB3 (0.44) | ITGB3ITGAVITGA2BKDM4EMAPK1 | |
| SCHEMBL8487967 | 0.90 | ITGB3 (0.42) | ITGB3ITGAVITGA2BKDM4EMAPK1 | |
| SCHEMBL14224072 | 0.89 | ITGB3 (0.43) | ITGB3ITGAVITGA2BKDM4EMAPK1 | |
| SCHEMBL14195949 | 0.74 | ITGB3 (0.48) | ITGB3ITGAVITGA2BDPP4ITGB5 | |
| SCHEMBL14195945 | 0.74 | ITGB3 (0.48) | ITGB3ITGAVITGA2BDPP4ITGB5 | |
| SCHEMBL4805768 | 0.74 | ITGB3 (0.48) | ITGB3ITGAVITGA2BDPP4ITGB5 | |
| SCHEMBL13344630 | 0.74 | ITGB3 (0.54) | ITGB3ITGAVITGA2BKDM4EMAPK1 | |
| SCHEMBL4394126 | 0.71 | ITGB3 (0.64) | ITGB3ITGAVITGA2BITGB5ITGB1 | |
| SCHEMBL4716833 | 0.71 | ITGB3 (0.56) | ITGB3ITGAVITGA2BKDM4EITGB5 | |
| SCHEMBL14224073 | 0.70 | ITGB3 (0.43) | ITGB3ITGAVITGA2BDPP4ITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506779-A1 | (3-(4-(Pyridin-2-ylamino)-butyryl)-2,3,4,4a,9,9a-hexahydro-1H-3-aza-fluoren-9-yl)-acetic acid derivatives and related tricyclic indanyls as alphaVbeta3 and alphaVbeta5 integrin inhibitors for the treatment of cancer and unstable angina | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-16 | — | — | EP | disclosed |